Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0000950123-23-002979
Filing Date
2023-03-22
Accepted
2023-03-22 09:40:29
Documents
9

Document Format Files

Seq Description Document Type Size
1 f-1_march_2023_pipe.htm F-1 685528
2 vrax-ex5_1.htm EX-5 99491
3 vrax-ex21_1.htm EX-21 13804
4 vrax-ex23_1.htm EX-23 8268
5 EX-FILING FEES vrax-ex99_1.htm EX-FILING FEES 67569
6 img31172669_0.jpg GRAPHIC 14742
7 img31172669_1.jpg GRAPHIC 69418
8 img31172669_2.jpg GRAPHIC 14742
9 img35431341_0.jpg GRAPHIC 3836
  Complete submission text file 0000950123-23-002979.txt   1017671
Mailing Address 30 BROADWICK STREET LONDON X0 W1F 8LX
Business Address 30 BROADWICK STREET LONDON X0 W1F 8LX 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-270734 | Film No.: 23751630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances